Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Lembke

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Addiction (Abingdon, England)|January 12, 2024
Trends in hallucinogen-associated emergency department visits and hospitalizations in California, USA, from 2016 to 2022Nicolas Garel, Steven Tate, Kristin Nash, et al.
Journal of Addictive Diseases|April 22, 2020
Online mutual-help intervention for reducing heavy alcohol useNancy A Haug, Emily E Morimoto, Anna Lembke
Clinical EEG and Neuroscience|April 29, 2004
Current status of the utilization of antiepileptic treatments in mood, anxiety and aggression: drugs and devicesJohn J Barry, Anna Lembke, Kim D Bullock
International Journal of Environmental Research and Public Health|December 23, 2022
Buprenorphine Microdosing Cross Tapers: A Time for ChangeAmer Raheemullah, Ori-Michael Benhamou, Jamie Kuo, et al.
Journal of Addictive Diseases|July 12, 2022
A telehealth inpatient addiction consult service is both feasible and effective in reducing readmission ratesHuiqiong Deng, Amer Raheemullah, Lief E Fenno, et al.
Journal of Substance Abuse Treatment|July 3, 2021
A systematic review of stigma interventions for providers who treat patients with substance use disordersJennifer Bielenberg, Gabrielle Swisher, Anna Lembke, et al.
Substance Abuse|February 11, 2016
Assessment of provider attitudes toward #naloxone on TwitterNancy A Haug, Jennifer Bielenberg, Steven H Linder, et al.
Anesthesiology Clinics|August 11, 2018
Perioperative Considerations for the Patient with Opioid Use Disorder on Buprenorphine, Methadone, or Naltrexone Maintenance TherapyThomas Kyle Harrison, Howard Kornfeld, Anuj Kailash Aggarwal, et al.
Journal of Clinical Psychopharmacology|January 8, 2004
A prospective trial of modafinil as an adjunctive treatment of major depressionCharles DeBattista, Anna Lembke, H Brent Solvason, et al.
Journal of Addictive Diseases|November 14, 2022
Qualitative exploration of the psychological dimensions of telehealth shared medical appointments (SMAs) for buprenorphine prescribingBen Greenberg, Anna C Oft, Lauren Lucitt, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Addiction (Abingdon, England)|January 12, 2024
Trends in hallucinogen-associated emergency department visits and hospitalizations in California, USA, from 2016 to 2022Nicolas Garel, Steven Tate, Kristin Nash, et al.
Journal of Addictive Diseases|April 22, 2020
Online mutual-help intervention for reducing heavy alcohol useNancy A Haug, Emily E Morimoto, Anna Lembke
Clinical EEG and Neuroscience|April 29, 2004
Current status of the utilization of antiepileptic treatments in mood, anxiety and aggression: drugs and devicesJohn J Barry, Anna Lembke, Kim D Bullock
International Journal of Environmental Research and Public Health|December 23, 2022
Buprenorphine Microdosing Cross Tapers: A Time for ChangeAmer Raheemullah, Ori-Michael Benhamou, Jamie Kuo, et al.
Journal of Addictive Diseases|July 12, 2022
A telehealth inpatient addiction consult service is both feasible and effective in reducing readmission ratesHuiqiong Deng, Amer Raheemullah, Lief E Fenno, et al.
Journal of Substance Abuse Treatment|July 3, 2021
A systematic review of stigma interventions for providers who treat patients with substance use disordersJennifer Bielenberg, Gabrielle Swisher, Anna Lembke, et al.
Substance Abuse|February 11, 2016
Assessment of provider attitudes toward #naloxone on TwitterNancy A Haug, Jennifer Bielenberg, Steven H Linder, et al.
Anesthesiology Clinics|August 11, 2018
Perioperative Considerations for the Patient with Opioid Use Disorder on Buprenorphine, Methadone, or Naltrexone Maintenance TherapyThomas Kyle Harrison, Howard Kornfeld, Anuj Kailash Aggarwal, et al.
Journal of Clinical Psychopharmacology|January 8, 2004
A prospective trial of modafinil as an adjunctive treatment of major depressionCharles DeBattista, Anna Lembke, H Brent Solvason, et al.
Journal of Addictive Diseases|November 14, 2022
Qualitative exploration of the psychological dimensions of telehealth shared medical appointments (SMAs) for buprenorphine prescribingBen Greenberg, Anna C Oft, Lauren Lucitt, et al.
Pageof 5